Hemodynamic Evaluation of Dose-response and Safety of Dry Powder Inhalation of Treprostinil
Clinical trial NCT03884465 · TERMINATED
Trial details
- NCT number
- NCT03884465
- Sponsor
- Liquidia Technologies, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-11
- Primary completion
- 2020-12-23
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.